Question 1: In your institution, is it routine to screen patients undergoing surgery to identify those at high risk for POPC? | ||
---|---|---|
Answer options | Response count | Response percentage (%) |
Yes | 174 | 48.7 |
No | 183 | 51.3 |
Question 2: If institutions were to routinely screen for patients at high risk for POPC and then provide a POPC reduction care bundle, what recommendations would you make for constituents of this care bundle? To be applied PRE-operatively: | ||
---|---|---|
Answer options | Response count | Response percentage (%) |
Chlorhexidine mouthwash | 155 | 50.5 |
Selective oral decontamination (SOD), e.g. anti-microbial paste | 34 | 11.1 |
Selective digestive decontamination (SDD), e.g. non-absorbable enteral antibiotics and IV antibiotics | 24 | 7.8 |
Oral care, e.g. toothbrushing, dental hygienist review etc. | 147 | 47.9 |
Supervised exercise programme, also known as pre-habilitation | 140 | 45.6 |
Nebulised/inhaled medical therapy | 94 | 30.6 |
Enteral/intravenous medical therapy | 39 | 12.7 |
Incentive spirometry or positive end-expiratory pressure valve | 197 | 64.2 |
Inspiratory muscle training | 169 | 55.0 |
Question 3: If institutions were to routinely screen for patients at high-risk for POPC and then provide a POPC-reduction care bundle, what recommendations would you make for constituents of this care bundle? To be applied INTRA-operatively: | ||
---|---|---|
Answer options | Response count | Response percentage (%) |
Low tidal volume ventilation, e.g. 6–8 mL/kg tidal volumes | 286 | 84.6 |
Appropriate PEEP | 251 | 74.3 |
Regular recruitment manoeuvres | 141 | 41.7 |
Endotracheal tube with subglottic secretion drainage | 101 | 29.9 |
Nebulised antibiotics | 9 | 2.7 |
Avoid blood transfusion by tolerating anaemia unless Hb ≤ 70 g/L | 193 | 57.1 |
Use humidified ventilator circuit | 182 | 53.8 |
Avoid neuromuscular blockade (NMB) other than short-acting NMB for intubation | 147 | 43.5 |
Specific methods to evaluate or reverse NMB | 117 | 34.6 |
Fluid resuscitation using advanced monitoring (EVLWI or lung US) to avoid pulmonary oedema | 147 | 43.5 |
Avoid hyperoxia (saturations ≥ 99% or PaO2 ≥ 14 kPa) | 206 | 60.9 |
Anti-sialogogues, e.g. glycopyrronium | 40 | 11.8 |
Question 4: If institutions were to routinely screen for patients at high risk for POPC and then provide a POPC-reduction care bundle, what recommendations would you make for constituents of this care bundle? To be applied POST-operatively: | ||
---|---|---|
Answer options | Response count | Response percentage (%) |
High-flow humidified oxygen via nasal cannulae | 158 | 46.3 |
CPAP administered via facemask or hood | 174 | 51.0 |
Extubation directly onto bi-level positive pressure ventilation via face mask in all patients | 38 | 11.1 |
Extubation directly onto bi-level positive pressure ventilation via face mask in selected patients | 105 | 30.8 |
Incentive spirometry/regular use of positive end-expiratory pressure valve | 187 | 54.8 |
Inspiratory muscle training | 162 | 47.5 |
Specific physical therapy or exercises, additional to ERAS early mobilisation | 147 | 43.1 |
Avoid use of gastric acid suppression medications | 96 | 28.2 |
Head of bed elevation | 309 | 90.6 |
Mini-tracheostomy to permit suctioning of airway secretions | 13 | 3.8 |
Avoidance of hyperoxia (saturations ≥ 99% or PaO2 ≥ 14 kPa) | 194 | 56.9 |
Question 5: Would you potentially be interested in assessing the feasibility of using this care bundle approach in patients who are at high risk of POPC in your institution? | ||
---|---|---|
Answer options | Response count | Response percentage (%) |
Yes | 242 | 79.1 |
No | 64 | 20.9 |
Question 6: Once feasibility has been assessed, might your institution be interested in participating in an international multi-centre clinical trial assessing the effectiveness of a POPC reduction care bundle? | ||
---|---|---|
Answer options | Response count | Response percentage (%) |
Yes | 239 | 78.1 |
No | 67 | 21.9 |